Blood loss and the need for transfusion in patients who undergo partial or radical nephrectomy for renal cell carcinoma

Journal of Urology

Volumn 164, Issue 4, 2000, Pages 1160-1163

  Shvarts, Oleg ^a   Tsui, Ke Hung ^a   Smith, Robert B ^a   De Kernion, Jean B ^a   Belldegrun, Arie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autologous; Blood transfusion; Carcinoma; Kidney; Nephrectomy; Renal cell

Indexed keywords

ERYTHROPOIETIN;

ARTICLE; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CONTROLLED STUDY; HEMATOCRIT; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; NEPHRECTOMY; PARTIAL NEPHRECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0033813029     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67132-7     Document Type: Article

References (20)

1. The effect of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation: The American Erythropoietin Study Group
2. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoietin alfa in orthopedic surgery patients
3. A safety and efficacy comparison study of two dosing regimens of epoietin alfa in patients undergoing major orthopedic surgery
4. Efficacy of preoperative donation of blood for autologous use in radical prosatectomy
5. Impact of autologous blood transfusions on patients undergoing radical prostatectomy using hypotensive anesthesia
6. Renal cell carcinoma: Earlier discovery and increased detection
7. Increased incidental detection and reduced mortality in renal cancer - Recent retrospective analysis at eight institutions
8. Complications of nephron sparing surgery for renal tumors
9. Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval, and atrial extension
10. Renal tumors
11. TNM staging of renal cell carcinoma. Workgroup No. 3, Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)
12. Blood loss during radical retropubic prosatectomy: Is preoperative autologous blood donation indicated?
13. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States
14. Safety of the blood supply
15. The cost effectiveness of preoperative autologous blood donations
16. Decreased erythropoietin response in patients with the anemia of cancer
17. Autologous blood donation prior to anatomical radical retropubic prostatectomy: Is it necessary?
18. Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy
19. Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment
20. Preoperative recombinant human erythropietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy